Altrumed LLC

Philadelphia, PA

UEI
J8F3W4SWZ944
CAGE
94GQ7
Primary NAICS
621999 All Other Miscellaneous Ambulatory Health Care Services
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
3401 Grays Ferry Ave Bldg 450 Ste 1067, Philadelphia, PA 19146, USA
Website
altru-med.com
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Children's Research Institute Alliance for Pediatric Device Innovation - main P50FD007965 $50,000

Similar vendors

Vendor Location Primary NAICS
Autonomous Healthcare Inc. UEI MTDYDS8M2176 Santa Clara, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Real Prevention LLC UEI DALPEA4VNNJ3 West Orange, NJ —
Sano Healthcare Consultants, LLC UEI J3ZMNL9BXQ11 Ontario, CA 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
Neurotype Inc. UEI CKJEWEVBWP54 Duluth, MN —
Pascall Systems, Inc. UEI PX3XJYHFN4S1 Cambridge, MA —

About the company

Altrumed LLC, a for-profit medical device company based in Philadelphia, Pennsylvania, acts as a federal grant recipient developing wearable opioid overdose detection and alert systems for the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279). The vendor operates primarily as a prime recipient (75% of recent awards) with minimal sub-award activity, focused on a single technology platform across a narrow federal customer base.

Altrumed's capability portfolio centers on the DOVE device, a shoulder-worn wearable smaller than a smartwatch that uses next-generation pulse oximetry and shoulder-based reflectance optical spectroscopy to detect opioid-induced respiratory suppression and automatically alert first responders and nearby bystanders. The vendor received a $403,307 grant from NIDA on September 1, 2026, running through August 31, 2027, to optimize and clinically validate the DOVE sensor across diverse populations, with technical refinements to enhance optical penetration depth, sensor arrangement, and luminosity while normalizing biomarker readings across skin tones. Altrumed completed a 100-patient user preference study demonstrating 71 percent of surveyed high-risk opioid users expressed strong interest in a sense-and-alert system. Earlier grants funded device development and commercialization validation: a May 1, 2023, NIDA award (completion April 30, 2025) supported optimization and testing of harness, sensor, and automatic injector components; an August 15, 2025, award (completion April 30, 2027) funds development of device-agnostic hypoxia detection software integrating algorithms that analyze oxygen saturation, respiratory rates, and motion patterns to enable tailored interventions including naloxone redosing or bag-valve-mask ventilation.

Customer concentration is absolute — the National Institute on Drug Abuse accounts for 100 percent of prime awards across the footprint. Altrumed also appears as a sub-award recipient on a sub-grant from the Children's Research Institute under the Alliance for Pediatric Device Innovation (awarded November 12, 2024). Activity has been steady at one award per year since 2023. Two awards reach ultimate completion inside the next twenty-four months, triggering potential recompete exposure.

Quick answers

Is Altrumed LLC registered in SAM.gov?

Yes. Altrumed LLC's SAM.gov registration is active through December 8, 2026.

What is Altrumed LLC's CAGE code?

Altrumed LLC's CAGE code is 94GQ7, and its Unique Entity ID (UEI) is J8F3W4SWZ944.

What is Altrumed LLC's most recent federal award?

Altrumed LLC's most recent federal grant award is Responding to the opioid crisis with dove: a standalone opioid overdose detection and alert device (R44DA063251), from National Institute on Drug Abuse (NIH), on September 1, 2026.

On GovTribe

See Altrumed LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe